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cally important aspect of studies of cognitive change: prac-
tice and retest effects in repeatedly observed cognitive test
performance. Practice and retest effects are large, pervasive,
and underappreciated. By large, I mean that average gains on
repeat administration are often much greater than normative
cognitive change over a similar interval [2]. By pervasive, I
mean that practice and retest effects are seen for a wide vari-
ety of cognitive tests assessing different domains of func-
tioning [3]. By underappreciated, I mean that despite a
long-standing and enduring literature [4,5], investigators
continue to develop protocols that reveal a failure to
consider the full range of impact of practice and retest
effects [6].
Goldberg et al. focus their review on the potential impact
of practice and retest effects in randomized controlled trials
in preclinical Alzheimer’s disease. Of the range of potential
uses of serial cognitive assessment—including clinical prac-
tice and observational and natural history studies—one
might assume that randomized controlled trials may be a
context in which practice and retest effects are of the least
concern. This is because, as the thinking goes, even if prac-
tice and retest effects are observed, they should be present in
equal measure in our randomly assigned control and active
treatment groups and cancel out in group comparisons of
treatment effects. Goldberg et al. argue that the assumption
that practice and retest effects are equivalent in treated and
controls may not be justified, and moreover that practice
and retest effects may result from cognitive processes that
are potentially distinct from the one intended to be measured
with a given test. This is potentially important for emerging
studies of disease-modifying therapies for Alzheimer’s
disease.
Perhaps, one of the reasons why some studies fail to plan
for practice and retest effects in design and/or analysis is the
lack of consensus on best methods. Thorndike [4] suggested
practice and retest effects could be eliminated with 10 mi-
nutes of practice (similar to the massed practice approach
by Goldberg et al.), but this does not eliminate practice
and retest effects from performance, only from collected
data. If practice and retest effects have inferential value
(c.f., [7]), then this approach is not useful. Goldberg et al.
recommend the use of alternate forms but also note criticalhttp://dx.doi.org/10.1016/j.dadm.2015.02.002
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creativecommons.org/licenses/by-nc-nd/4.0/).limitations of this approach. The literature suggests that
alternate forms may attenuate but do not eliminate practice
and retest effects [8]. If forms are not psychometrically
equivalent and are not administered in a counterbalanced
and randomized order, the use of alternate forms can intro-
duce as much construct-irrelevant variance as practice and
retest effects [6,9]. As Goldberg et al. mention, reliable
change indices (RCIs), with correction for practice [10],
have a certain appeal. However, early proponents of RCIs
now favor regression-based approaches [11], and not all au-
thors have found practice-corrected RCIs to be useful in the
context of randomized controlled trials [12].
Another approach to deal with practice and retest effects
not mentioned by Goldberg et al. is statistical modeling in
repeated-measures designs with linear mixed effect or
related data analysis approaches [13,14]. Hoffman et al.
[15] offer the important caveat that in typical fixed-interval
designs involving age-heterogeneous samples, such ap-
proaches are in general not informative about retest effects
because of the confounding of age differences and retest-
related gains [15]. These authors suggest instead a seldom-
used approach to assessment and modeling of cognitive
performance data: the “measurement burst” design [16].
The goal of such designs is to model individual variability
in repeat administration over a short enough interval to
render aging effects negligible and model aging trends
with repeated short-interval bursts of measurement over
longer intervals. Salthouse [17] has used such approaches
in the study of cognitive performance and revealed impor-
tant and deeper complexities associated with the practice
and retest effect. Not only can we expect age differences
in the magnitude of retest-related gains (which may be of
clinical relevance [7]), but the retention of retest-related
gains over longer intervals is also revealed as a potentially
important individual difference factor and one that con-
founds but is not conceptually equivalent to aging-related
change in cognitive ability.
Despite a century of research, there is no clear consensus
on the best methods to address the (still-emerging) impact of
practice and retest effects. Nevertheless, recommendation by
Goldberg et al. to use tests designed to minimize practice and
retest effects without changing the fundamental construct of
interest is a good one. Investigators should be wary ofhis is an open access article under the CC BY-NC-ND license (http://
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do not include counterbalancing [6]. The development of
cognitive tests calibrated with item response theory methods
and administered in an adaptive fashion, such as the NIH
Toolbox [18], offers great potential in this regard. In comput-
erized adaptive testing, psychometric equivalence and effec-
tive counterbalancing can be incorporated into the adaptive
testing procedure. A plan for using design and analysis fea-
tures (e.g., control or comparison groups, measurement burst
design) to adjust and/or model the impact of practice and re-
test effects is now something that reviewers should expect to
see in research proposals.
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